Login / Signup

Tacrolimus 4-hour monitoring in liver transplant patients is non-inferior to trough monitoring: The randomized controlled FK04 trial.

Bastian N RuijterMaarten E TushuizenDirk J A R MoesBabs M de KlerkBart van Hoek
Published in: Clinical transplantation (2022)
Tacrolimus 4-hour monitoring in stable LT patients is not superior to trough monitoring, regarding the effect on renal function, but is safe for use to facilitate tacrolimus monitoring in an afternoon outpatient clinic.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • blood pressure
  • primary care
  • clinical trial
  • phase iii
  • randomized controlled trial
  • study protocol
  • phase ii